IXC 2.86% 7.2¢ invex therapeutics ltd

Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial, page-18

  1. 941 Posts.
    lightbulb Created with Sketch. 302
    Yes, given the relatively straightforward design of the trial and the endpoints and given the magnitude of the effect we are expecting to see, I can not see it taking more than 3 months from unblinding to readout.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.0¢ 7.2¢ 6.6¢ $3.476K 50.58K

Buyers (Bids)

No. Vol. Price($)
1 29320 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 13.58pm 23/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.